Version 2.5.2.0 CRISP Logo CRISP Homepage Help for CRISP Email Us

Abstract

Grant Number: 2R44GM074292-02
Project Title: Amphiphilic Polycations for Nucleic Acid Delivery
PI Information:NameEmailTitle
ROZEMA, DAVID B. dave.rozema@mirusbio.com

Abstract: DESCRIPTION (provided by applicant): Given its central role in metabolism, the secretion of circulating proteins, and infectious disorders, a large number of genetic or acquired disorders could be corrected by liver-directed delivery of nucleic acids to instill beneficial functions or inhibit deleterious ones. However, a safe and effective delivery method for transferring nucleic acids molecules to hepatocytes remains to be perfected. To date, most in vivo nucleic acid delivery vehicles have been colloid particles with size grater than 50 nm. We believe that we have found an innovative strategy for the delivery of molecular conjugates of siRNA. This formulation relies upon several new innovations: the development-as a result of Phase I research- of membrane lytic polymers, the ability to reversibly mask the positive charges of these polymers until they reach an acidic environment such as the endosome/lysosome, the ability to target these masked membrane lytic polymers to hepatocytes in vivo, and the formation of siRNA-polymer conjugates that like polymers can be targeted to hepatocytes in vivo.

Thesaurus Terms:

There are no thesaurus terms on file for this project.

Institution: MIRUS BIO CORPORATION
505 SOUTH ROSA ROAD, STE 104
MADISON, WI 537191264
Fiscal Year: 2007
Department:
Project Start: 01-SEP-2005
Project End: 31-MAR-2009
ICD: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
IRG: ZRG1


CRISP Homepage Help for CRISP Email Us